Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4066 AL 4080

[Micturition disorders in people aged 65 and more]

Wróbel M, Zapołoch S, Skawina I.

Med Pr. 2025 Sep 8;76(3):199-207. doi: 10.13075/mp.5893.01623. Epub 2025 Jul 14.

Use of safinamide for treatment of Parkinson disease: real-world data from Spain

Morales Casado MI, López Ariztegui N.

Drugs Context. 2025 Jul 25;14:2025-5-5. doi: 10.7573/dic.2025-5-5. eCollection 2025.

Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging

Sen MK, Dunville K, Miles N, Newbery M, Ng NS, Ooi L.

Front Cell Neurosci. 2025 Jul 15;19:1650938. doi: 10.3389/fncel.2025.1650938. eCollection 2025.

Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols

Cao X, Cui X, Badehnoosh B.

Food Sci Nutr. 2025 Jul 28;13(8):e70696. doi: 10.1002/fsn3.70696. eCollection 2025 Aug.

Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's disease

Auffret M, Borovecki F, Heim B, Jost WH, Odin P, Stocchi F, Trost M, Vérin M.

J Neural Transm (Vienna). 2025 Nov;132(11):1727-1750. doi: 10.1007/s00702-025-02989-x. Epub 2025 Jul 30.

Effect of natural compounds on NRF2/KEAP1 signaling in periodontitis: a potential use to prevent age-related disorders

Tossetta G, Fantone S, Olivieri F, Mazzucchelli R, Togni L, Santarelli A, Marzioni D, Rippo MR.

Mol Biol Rep. 2025 Jul 30;52(1):771. doi: 10.1007/s11033-025-10878-5.

Reply: Immersive virtual reality for cognitive training in Parkinson's disease - Future directions and neuroimaging perspectives

Fiorenzato E, Zabberoni S, Costa A, Antonini A, Cona G.

J Neurol Sci. 2025 Sep 15;476:123636. doi: 10.1016/j.jns.2025.123636. Epub 2025 Jul 25.

From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics

Roy A, Dawson VL, Dawson TM.

Neurotherapeutics. 2025 Sep;22(5):e00712. doi: 10.1016/j.neurot.2025.e00712. Epub 2025 Jul 29.

Comment on "Circulating cell-free DNA as predictors of Parkinson's disease"

Raparthi A, Bavurothu SK.

Parkinsonism Relat Disord. 2025 Oct;139:107976. doi: 10.1016/j.parkreldis.2025.107976. Epub 2025 Jul 28.

Advancements in invasive and non-invasive neuromodulation for Parkinson's disease: current findings and future directions

Koirala N, Bange M, Wagle Shukla A, Muthuraman M.

NPJ Parkinsons Dis. 2025 Jul 30;11(1):221. doi: 10.1038/s41531-025-01071-3.

Poor sleep quality among patients with Parkinson's disease: a meta-analysis and systematic review

Si TL, Wang YY, Li JX, Bai W, Sun HL, Rao SY, Zhu HY, Ungvari GS, Su Z, Cheung T, Ng CH, Xiang YT, Wang G.

Front Psychiatry. 2025 Jul 16;16:1606743. doi: 10.3389/fpsyt.2025.1606743. eCollection 2025.

Wolff-Parkinson-White syndrome case due to a coronary sinus accessory pathway in a patient with unique congenital coronary venous anomaly: a case report

Conti R, Forzati N, Iacopino S, Petretta A, Squeri A.

Eur Heart J Case Rep. 2025 Jul 16;9(7):ytaf336. doi: 10.1093/ehjcr/ytaf336. eCollection 2025 Jul.

Adaptive immunity in the pathogenesis and treatments of Parkinson's disease

Du X, Akter S, Oludipe DB, Sil S, Zhang C, Gendelman HE, Mosley RL.

NeuroImmune Pharm Ther. 2025 Jun 20;4(2):273-284. doi: 10.1515/nipt-2025-0008. eCollection 2025 Jun.

Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders

Zhang Y, Zhang T, Zhao M, Li P, Liu T, Xie J.

Front Pharmacol. 2025 Jul 16;16:1618623. doi: 10.3389/fphar.2025.1618623. eCollection 2025.

A Case Report of Clozapine-Induced Cardiomyopathy

Gourisaria G, Sumanasan N, Ozen G, Konduru TS, Karunakaran Thozhuthumparambil P.

Cureus. 2025 Jun 30;17(6):e87032. doi: 10.7759/cureus.87032. eCollection 2025 Jun.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias